Methods are disclosed for treating congestive heart failure with partial inhibitors of fatty acid oxidation. The compounds increase cardiac performance without affecting heart rate, blood pressure, or oxygen consumption.
This application claims priority to U.S. Provisional Application Ser. No. 60/183,560, filed Feb. 18, 2000, and U.S. Provisional Application Ser. No. 60/219,908, filed Jul. 21, 2000 the specifications of each of which are incorporated herein by reference.
Methods are disclosed for treating congestive heart failure with partial inhibitors of fatty acid oxidation. The compounds increase cardiac performance without affecting heart rate, blood pressure, or oxygen consumption.
